Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:34 PM
Ignite Modification Date:
2025-12-24 @ 11:34 PM
NCT ID:
NCT03745456
Eligibility Criteria:
Inclusion Criteria:
* Consecutive patients with severe subarachnoid hemorrhage (Hunt and Hess 4-5, Fisher 3-4) will be included initially in the first 6 hours after the onset of symptoms.
Exclusion Criteria:
1. Patient with known coagulopathy or with ingestion of antiplatelet drugs or anticoagulants in the 15 days prior to the presentation of symptoms.
2. Patients in whom there is no confirmed arteriovenous malformation.
3. The patient or authorized family member denies informed consent.
4. High risk of imminent death, evaluated by the doctor in charge of the patient.
5. Hemoglobin \<100 g / L and / or platelet count \<100,000 microL
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03745456
Study Brief:
Protocol Section:
NCT03745456